<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aberrant expression of the antiapoptotic protein BCL (B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>)-2 in neoplastic germinal centers is one of the diagnostic hallmarks of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>If BCL-2 cannot be detected by immunohistochemistry, the distinction between florid <z:hpo ids='HP_0002729'>follicular hyperplasia</z:hpo> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> might become a diagnostic challenge </plain></SENT>
<SENT sid="2" pm="."><plain>Most of those cases also lack the typical t(14;18), and the underlying pathophysiologic conditions of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> that lack BCL-2 protein expression are largely unknown </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we collected 18 BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases from 5 different institutions </plain></SENT>
<SENT sid="4" pm="."><plain>After restaining, 9 cases proved to be truly BCL-2 negative (6 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade 2, 2 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade 3a, and 1 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> grade 3b) </plain></SENT>
<SENT sid="5" pm="."><plain>In 4 additional cases, BCL-2 was very faint (<z:hpo ids='HP_0000001'>all</z:hpo> grade 2) </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 9 BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases, 2 were negative for CD10 (22%); <z:hpo ids='HP_0000001'>all</z:hpo> showed expression of BCL-6 </plain></SENT>
<SENT sid="7" pm="."><plain>Apoptotic level as determined by caspase 3 was the lowest in the BCL-2-positive follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> group (15 ± 8 mm(2)), the highest in the <z:mpath ids='MPATH_458'>normal</z:mpath>/reactive group (n = 7, 60 ± 12 mm(2)) and very similar in the BCL-2 low follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> groups (25 ± 13 and 33 ± 19 mm(2), respectively), assuming an intermediate position between reactive follicles and BCL-2-positive neoplastic follicles (P &lt; .001 [Kruskal-Wallis]) </plain></SENT>
<SENT sid="8" pm="."><plain>Also noted was a difference in proliferation fractions between the BCL-2-positive follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (27% ± 15%), the BCL-2 low follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (30% ± 20%) and the BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> groups (30% ± 22%) </plain></SENT>
<SENT sid="9" pm="."><plain>Regarding the network of follicular dendritic cells, 8 (89%) of 9 cases from the BCL-2-negative subgroup showed disrupted, weakly developed networks, whereas <z:hpo ids='HP_0000001'>all</z:hpo> of the follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> BCL-2 low-expression cases showed a well-defined and strongly developed follicular dendritic cell network </plain></SENT>
<SENT sid="10" pm="."><plain>Among BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, BCL-2 and BCL-6 breaks were found in 1 case each, whereas in the follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> BCL-2 low group, only 1 case with a BCL-6 break was recorded </plain></SENT>
<SENT sid="11" pm="."><plain>No statistically significant result was achieved upon assessment of BCL-2α or BCL-2β <z:chebi fb="40" ids="33697">RNA</z:chebi> or the ratio of α/β isolated by real-time-polymerase chain reaction </plain></SENT>
<SENT sid="12" pm="."><plain>Taken together, BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> did not show a BCL-2 break on the genetic level and showed both increased apoptotic and proliferation rates compared with BCL-2-positive follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="13" pm="."><plain>In our series, BCL-6 breaks were infrequent in BCL-2-negative follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
</text></document>